Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of orelabrutinib, obinutuzumab, and lenalidomide in previously untreated marginal zone lymphoma: Preliminary results from a prospective, single-arm, multicenter, Phase II study

Wei Wang, Yueying Mao, Jing Ruan, Huacong Cai, Jin Ye, JunLi Chen, Liang Wang, Wenrong Huang, Yan Zhang, Jian Li

Blood (2025) 146 (Supplement 1): 5383.

https://doi.org/10.1182/blood-2025-5383

Published: 2025

Journal Articles

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate-high risk DLBCL patients?

Shuozi Liu, Lan Ma, Hui Liu, Jiefei Bai, Wenrong Huang, JunLi Chen, Li Bao, Shan Gao, Wanling Sun, Zhenling Li, Min Wang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 1888.

https://doi.org/10.1182/blood-2025-1888

Published: 2025

Journal Articles

Efficacy of Zanubrutinib Combined with Immunochemotherapy in Newly Diagnosed MYD88-Mutated Diffuse Large B-Cell Lymphoma: A Retrospective Single-Center Study

Wenrong Huang, Xiubin Xiao, Xilin Chen, Shunzong Yuan, Yi Ma, Shihua Zhao, Yun Lu, Junli Chen, Nana Cheng, Hua Yin, Feng Pan, Yueqi Wang

Blood (2024) 144 (Supplement 1): 6528.

https://doi.org/10.1182/blood-2024-201880

Published: 2024

Journal Articles

Daratumumab Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Yi Ma, Xiubin Xiao, Shunzong Yuan, Xilin Chen, Shihua Zhao, Nana Cheng, Yun Lu, Junli Chen, Yueqi Wang, Wenrong Huang

Blood (2023) 142 (Supplement 1): 6687.

https://doi.org/10.1182/blood-2023-184811

Published: 2023

Journal Articles

Efficacy of Hetrombopag in Treatment of Cancer Therapy-Induced Thrombocytopenia in Lymphoma and Multiple Myeloma Patients

Wen-Rong Huang, Junli Chen

Blood (2023) 142 (Supplement 1): 3970.

https://doi.org/10.1182/blood-2023-179702

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Efficacy and safety of orelabrutinib, obinutuzumab, and lenalidomide in previously untreated marginal zone lymphoma: Preliminary results from a prospective, single-arm, multicenter, Phase II study

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate-high risk DLBCL patients?

Efficacy of Zanubrutinib Combined with Immunochemotherapy in Newly Diagnosed MYD88-Mutated Diffuse Large B-Cell Lymphoma: A Retrospective Single-Center Study

Daratumumab Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Efficacy of Hetrombopag in Treatment of Cancer Therapy-Induced Thrombocytopenia in Lymphoma and Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Efficacy and safety of orelabrutinib, obinutuzumab, and lenalidomide in previously untreated marginal zone lymphoma: Preliminary results from a prospective, single-arm, multicenter, Phase II study

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate-high risk DLBCL patients?

Efficacy of Zanubrutinib Combined with Immunochemotherapy in Newly Diagnosed MYD88-Mutated Diffuse Large B-Cell Lymphoma: A Retrospective Single-Center Study

Daratumumab Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Efficacy of Hetrombopag in Treatment of Cancer Therapy-Induced Thrombocytopenia in Lymphoma and Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only